Follow-up of a National Cohort of Melanoma Resectable Stage II, Stage III or IV Patients or Unresectable Primary
Conditions
Interventions
- OTHER: Biological
- OTHER: Tissular
- OTHER: Quality of life
Sponsor
Assistance Publique - Hôpitaux de Paris
Collaborators